Tag: TCT 2024
TCT 2024 hears early experience with high-definition IVUS system
Details of early studies using a dual-frequency intravascular ultrasound (IVUS) imaging system w...
ACURATE IDE results put spotlight on impact of valve under-expansion after TAVI
“Disappointed is an understatement,” Michael Reardon (Houston Methodist DeBakey Heart & Vasc...
Attention turns to multi-organ denervation as new evidence supports “durability” of blood pressure reductions
New research will investigate the safety and efficacy of multi-organ, hepatic artery and renal a...
Early valve replacement falls short in EVOLVED trial
The question of early intervention among patients with severe aortic stenosis but no symptoms st...
Orbital atherectomy fails to eclipse balloon angioplasty in randomised trial in severely calcified lesions
The routine use of orbital atherectomy prior to percutaneous coronary intervention (PCI) in seve...
Trilogy valve shows favourable results at two years in aortic regurgitation patients
Latest data from the ALIGN AR trial, investigating the use of the Trilogy (JenaValve) transcathe...
CONFIRM-2 registry demonstrates use of AI-enabled quantitative CT for predicting MACE
Late-breaking study results were presented at the TCT 2024 conference as part of the CONFIRM-2 g...
Initial results of Sikelia transcatheter heart valve shared at TCT 2024
MitrAssist Lifesciences has announced initial clinical results of its Sikelia transcatheter heart va...
TCT 2024: Drug-eluting resorbable scaffold proves cost effective at one year in LIFE-BTK analysis
A retrospective economic analysis of the LIFE-BTK trial has demonstrated the one-year cost-effec...
TCT 2024 hears one-year results of TRAVEL II study of transcatheter tricuspid replacement system
One-year outcomes of the TRAVEL II study, evaluating the Lux-Valve Plus (Jenscare Scientific) tr...
TCT 2024: Six-month data reflect safety and efficacy of Lithix HC-IVL system
Six-month data from the PINNACLE I study evaluating the safety and performance of the LithiX Her...
TCT 2024: TRISCEND II reports positive outcomes for tricuspid replacement system
The Evoque (Edwards Lifesciences) tricuspid valve replacement system demonstrated superiority co...
TCT 2024: New analysis shows difference in rates of stroke among US and non-US cohorts of PROTECTED TAVR trial
New analysis of the PROTECTED TAVR trial has shown a reduction in stroke within the US portion o...
TCT 2024: Two-year SPYRAL HTN-ON MED show “consistent” effect of renal denervation
Medtronic has announced new, long-term data from the SPYRAL HTN-ON MED clinical trial that showe...
TCT 2024: PEERLESS trial finds large-bore mechanical thrombectomy superior for intermediate-risk PE
Findings from the first international randomised controlled trial (RCT) to compare patient outco...
TCT 2024: One-year data from SIRONA trial show similar results for sirolimus versus paclitaxel DCB
Data from the prospective, multicentre, investigator-initiated SIRONA randomised clinical trial ...
TCT 2024: New evidence could prompt rethink over use of colchicine following acute MI
The largest trial to date to study the impact of colchicine—an anti-inflammatory medicine common...
TCT 2024: PATCH study reports initial positive results for sutureless vascular closure system
Vivasure Medical has announced initial positive results from its US IDE PATCH pivotal study eval...
TCT 2024: Coronary bioadaptor shows clinical benefit in complex PCI sub-groups
Late-breaking data from the INFINITY SWEDEHEART trial demonstrate significant benefit of the Dyn...
TCT 2024: EARLY TAVR shows early intervention may be fruitful in asymptomatic aortic stenosis
EARLY TAVR lived up to its billing as one of the most hotly anticipated trials to be presented a...
TCT 2024: TAVI does not shift the dial in heart failure patients with moderate aortic stenosis
Transcatheter aortic valve implantation (TAVI) was no better than a conservative, surveillance s...
TCT 2024: Adjustable valve replacement system wins Shark Tank innovation prize
Symbiosis, the developer of an adjustable transcatheter mitral valve replacement (TMVR) system—V...
TCT 2024: Seven-year registry data confirm use of AI-enabled FFRCT
HeartFlow has announced seven-year data confirming the use of its AI-enabled fractional flow res...
MedTech Innovation Forum returns at TCT 2024
Pressing issues in medtech innovation will be on the agenda on the opening day of the 2024 Trans...
